510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K020920Substantially Equivalent

Cozart Rapiscan Oral Fluid Drug Test - Opiate/methadone

Cozart Bioscience, Ltd., Oxfordshire Ox14 4ru, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K020920 is the FDA 510(k) clearance record for COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE, a class II device, cleared for Cozart Bioscience , Ltd. on under FDA product code DJG (Enzyme Immunoassay, Opiates). FDA records list 6 510(k) clearances for Cozart Bioscience , Ltd., from to . As of , FDA records show no recalls naming K020920.

Clearance record

Decision date
Received
(229 days to decision)
Product code
DJG Enzyme Immunoassay, Opiates
Regulation
21 CFR 862.3650
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Cozart Bioscience , Ltd. 45 Milton Park, Oxfordshire Ox14 4ru, GB
510(k) summary
Summary PDF
Third party review
No

Clearances, product code DJG

Trailing 12 months
3 clearances under product code DJG in the twelve months to October 2026, January 2026 the highest month at 3.
Show the numbers
Monthly 510(k) clearances under FDA product code DJG, trailing twelve months
MonthClearances
November 20250
December 20250
January 20263
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260